Reserved for EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option

50% off the $29.99 Customized Fix Kit. Use at checkout:

EPCLUSAINFO50

⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option

EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option

Unclaimed

AEO Score: 4/10

Monitoring for AI engine activity

In the Engagemii AEO index

epclusainfo.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option just got measured.

4/10 means EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option

Discover EPCLUSA® (sofosbuvir/velpatasvir), a prescription medicine used to treat chronic Hep C. See Important Safety Information including Important Warning.

Details

Industry: Healthcare

epclusainfo.com

AI Visibility Breakdown

1

Structured Data

5

Content Structure

6

Entity Clarity

2

E-E-A-T Signals

6

Technical AEO

2

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option: Health & Wellness

Trust Is the Product. AI Is How You Build It at Scale.

In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option.

Source & Attribution

Scored by Engagemii on July 9, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/epclusainfo

Cite this score: Engagemii (2026). "AEO Score for EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option." Retrieved from https://engagemii.com/aeo/brands/epclusainfo

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform